These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12686543)

  • 1. Crystal structure of varicella zoster virus thymidine kinase.
    Bird LE; Ren J; Wright A; Leslie KD; Degrève B; Balzarini J; Stammers DK
    J Biol Chem; 2003 Jul; 278(27):24680-7. PubMed ID: 12686543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homology modelling and docking studies on Varicella Zoster Virus Thymidine kinase.
    Spadola L; Novellino E; Folkers G; Scapozza L
    Eur J Med Chem; 2003 Apr; 38(4):413-9. PubMed ID: 12750029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations distal to the substrate site can affect varicella zoster virus thymidine kinase activity: implications for drug design.
    El Omari K; Liekens S; Bird LE; Balzarini J; Stammers DK
    Mol Pharmacol; 2006 Jun; 69(6):1891-6. PubMed ID: 16556772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics and crystal structure of the wild-type and the engineered Y101F mutant of Herpes simplex virus type 1 thymidine kinase interacting with (North)-methanocarba-thymidine.
    Prota A; Vogt J; Pilger B; Perozzo R; Wurth C; Marquez VE; Russ P; Schulz GE; Folkers G; Scapozza L
    Biochemistry; 2000 Aug; 39(31):9597-603. PubMed ID: 10924157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing the sensitivities of noncognate inhibitors to varicella zoster virus thymidine kinase: implications for postherpetic neuralgia therapy with existing agents.
    Yang L; Mo X; Yang H; Dai H; Tan F
    J Mol Model; 2014 Jul; 20(7):2321. PubMed ID: 24961898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific recognition of the bicyclic pyrimidine nucleoside analogs, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV-encoded thymidine kinase.
    Sienaert R; Naesens L; Brancale A; De Clercq E; McGuigan C; Balzarini J
    Mol Pharmacol; 2002 Feb; 61(2):249-54. PubMed ID: 11809847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs.
    Andrei G; Topalis D; Fiten P; McGuigan C; Balzarini J; Opdenakker G; Snoeck R
    J Virol; 2012 Mar; 86(5):2641-52. PubMed ID: 22190713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective abolishment of pyrimidine nucleoside kinase activity of herpes simplex virus type 1 thymidine kinase by mutation of alanine-167 to tyrosine.
    Degrève B; Esnouf R; De Clercq E; Balzarini J
    Mol Pharmacol; 2000 Dec; 58(6):1326-32. PubMed ID: 11093770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic studies of the predicted substrate-binding site of varicella-zoster virus thymidine kinase.
    Suzutani T; Davies LC; Honess RW
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1011-6. PubMed ID: 8389797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy of varicella-zoster virus by a novel class of highly specific anti-VZV bicyclic pyrimidine nucleosides.
    Balzarini J; McGuigan C
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):287-95. PubMed ID: 12084470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-azapyrimidine-2'-deoxy-4'-thionucleosides: antiviral agents against TK+ and TK- HSV and VZV strains.
    Maslen HL; Hughes D; Hursthouse M; De Clercq E; Balzarini J; Simons C
    J Med Chem; 2004 Oct; 47(22):5482-91. PubMed ID: 15481985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative inhibition of DNA polymerases from varicella zoster virus (TK+ and TK-) strains by (E)-5-(2-bromovinyl)-2'-deoxyuridine 5'-triphosphate.
    Yokota T; Konno K; Shigeta S; De Clercq E
    Mol Pharmacol; 1984 Sep; 26(2):376-80. PubMed ID: 6090888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering of a single conserved amino acid residue of herpes simplex virus type 1 thymidine kinase allows a predominant shift from pyrimidine to purine nucleoside phosphorylation.
    Balzarini J; Liekens S; Solaroli N; El Omari K; Stammers DK; Karlsson A
    J Biol Chem; 2006 Jul; 281(28):19273-9. PubMed ID: 16702226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Random mutagenesis of the thymidine kinase gene of varicella-zoster virus.
    Suzutani T; Lacey SF; Powell KL; Purifoy DJ; Honess RW
    J Virol; 1992 Apr; 66(4):2118-24. PubMed ID: 1312622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro synthesis of functional varicella zoster and herpes simplex viral thymidine kinase.
    Mahalingam R; Cabirac G; Wellish M; Gilden D; Vafai A
    Virus Genes; 1990 Jul; 4(2):105-20. PubMed ID: 1698324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS.
    Talarico CL; Phelps WC; Biron KK
    J Virol; 1993 Feb; 67(2):1024-33. PubMed ID: 8380452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of nucleotide sequence variations in herpes simplex virus types 1 and 2, and varicella-zoster virus.
    Chiba A; Suzutani T; Saijo M; Koyano S; Azuma M
    Acta Virol; 1998 Dec; 42(6):401-7. PubMed ID: 10358747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential intracellular compartmentalization of herpetic thymidine kinases (TKs) in TK gene-transfected tumor cells: molecular characterization of the nuclear localization signal of herpes simplex virus type 1 TK.
    Degrève B; Johansson M; De Clercq E; Karlsson A; Balzarini J
    J Virol; 1998 Dec; 72(12):9535-43. PubMed ID: 9811686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pseudoreceptor modelling study of the varicella-zoster virus and human thymidine kinase binding sites.
    Greenidge PA; Merz A; Folkers G
    J Comput Aided Mol Des; 1995 Dec; 9(6):473-8. PubMed ID: 8789189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase.
    Grignet-Debrus C; Cool V; Baudson N; Degrève B; Balzarini J; De Leval L; Debrus S; Velu T; Calberg-Bacq CM
    Cancer Gene Ther; 2000 Feb; 7(2):215-23. PubMed ID: 10770629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.